Search results
Will Pfizer Stock Rebound To Its 2021 Highs Of $60?
Forbes· 1 day agoThis underperformance of Pfizer stock can be attributed to declining revenues after the surge in Covid-19 vaccine demand during the pandemic ...
Another COVID vaccine? Yes, and here’s why
Denver Post· 7 days agoVaccine manufacturers Pfizer and Moderna say they were prepared to make updated vaccines available in August, pending final FDA approval ...
COVID vaccine companies told to focus on KP.2 variant for fall shots, per FDA announcement
Fox News via Yahoo News· 3 days agoThe U.S. Food and Drug Administration (FDA) has recommended thatCOVID vaccine manufacturers update...
Covid-19 Pharma Stars Continue Their Quest To Set New Standards In Cancer Treatment
Benzinga via Yahoo Finance· 2 hours agoAstraZeneca PLC (NASDAQ: AZN) kicked off the week by receiving approval from the U.S. Food and Drug...
Pfizer Lingers Near 11-Year Low Despite Promising Cancer Drug Updates — Is It A Sell?
Investor's Business Daily· 6 days agoIt will be important to watch how Pfizer stock performs as the company shores up its pipeline and...
Results are looking promising for a combined COVID and flu vaccine—here's how it could benefit...
Medical Xpress· 3 days agoCombination vaccines have been successfully used for several decades in Australia and around the...
Pfizer: An Oversold Pharma Stock in Recovery
GuruFocus.com via Yahoo Finance· 6 days agoThis combination caused a mechanical reaction of profit squeeze, which is unlikely to be sustained as inflation stabilizes and Pfizer's revenue sources...
COVID Variant KP.3 Surges to Dominance—Here's What You Need to Know
Health via Yahoo News· 5 days agoCases are “stable or uncertain” in 18 others and are likely declining in one—Oklahoma. Do Vaccines...
Pfizer Inc. (NYSE:PFE) Shares Sold by Trust Co. of Vermont
ETF DAILY NEWS· 1 day agoTrust Co. of Vermont lessened its holdings in shares of Pfizer Inc. (NYSE:PFE – Free Report) by 13.5% in the fourth quarter, according to the company in its most recent filing ...
COVID vaccine companies told to focus on KP.2 variant for fall shots, per FDA announcement
Fox News· 3 days agoThe U.S. Food and Drug Administration (FDA) has recommended thatCOVID vaccine manufacturers update...